PE000547

Name	R.VYKPSAGN[H5N4FS2]NSLYR.D
Sequence	VYKPSAGNNSLYR
Glycans(s)	H5N4FS2 (N8)
Mod(s)
Molecular Weight	3836.588
Norm. RT	6.659
Protein	APOH (P02749)

Samples

Human Serum

DDA Transition Groups

	Exp. R.T.	Peak R.T.	Norm. R.T.	Prec. m/z	Prec. z	Inst.	Sample	Transitions
TG000981	15.611	15.563	6.303	955.652	4	Orbitrap	Human Serum	18
TG005274	29.723	29.711	1.827	955.652	4	Orbitrap	Human Serum	10
TG003670	18.005	18.013	7.104	955.652	4	Orbitrap	Human Serum	11
TG003693	18.005	17.978	7.014	1,273.867	3	Orbitrap	Human Serum	14
TG005486	29.464	29.482	2.297	955.652	4	Orbitrap	Human Serum	12
TG003142	17.725	17.484	7.266	955.652	4	Orbitrap	Human Serum	10
TG004866	19.574	19.544	5.591	955.652	4	Orbitrap	Human Serum	10
TG003147	17.725	17.450	7.178	1,273.867	3	Orbitrap	Human Serum	14

DIA Transition Groups

	Exp. R.T.	Peak R.T.	Norm. R.T.	Prec. m/z	Prec. z	Inst.	Sample	Intensity
TG006423	15.914	15.914	9.802	1,273.867	3	Orbitrap	Human Serum	7,097,660
TG008038	19.895	19.895	10.349	955.652	4	TripleTOF	Human Serum	304,869
TG008640	19.962	19.962	-0.036	955.652	4	TripleTOF	Human Serum	294,582
TG009256	20.242	20.242	7.281	955.652	4	TripleTOF	Human Serum	287,283
TG008934	19.649	19.649	7.248	955.652	4	TripleTOF	Human Serum	276,394
TG008333	20.030	20.030	1.258	955.652	4	TripleTOF	Human Serum	264,836
TG008357	20.030	20.030	1.260	1,273.867	3	TripleTOF	Human Serum	215,295
TG008666	19.965	19.965	-0.021	1,273.867	3	TripleTOF	Human Serum	214,510
TG008062	19.905	19.905	10.394	1,273.867	3	TripleTOF	Human Serum	213,659
TG008965	19.658	19.658	7.288	1,273.867	3	TripleTOF	Human Serum	133,891
TG009565	19.702	19.702	1.985	955.652	4	TripleTOF	Human Serum	133,876
TG009995	19.834	19.834	6.896	955.652	4	TripleTOF	Human Serum	120,923
TG004531	18.242	18.242	3.640	955.652	4	TripleTOF	Human Serum	395.175